The level of vascular endothelial growth factor as a predictor of a poor prognosis in osteosarcoma

Journal of Bone and Joint Surgery - Series B

Volumn 91, Issue 6, 2009, Pages 784-788

  Kaya, M ^a,b   Wada, T ^a,b   Nagoya, S ^a,b   Sasaki, M ^a,b   Matsumura, T ^a,b   Yamashita, T ^a,b  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; METASTASIS; OSTEOSARCOMA; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TUMOR VOLUME;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BONE NEOPLASMS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OSTEOSARCOMA; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 66349123855     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.91B6.21853     Document Type: Article

References (20)

1. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston: clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-1763
2. Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2001;2:667-673 (Pubitemid 33085812)
3. Takahashi Y, Tucker SL, Kitadai Y, et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 1997;132:541-546 (Pubitemid 27215097)
4. Linderholm B, Tavelin B, Grankvist K, Henriksson R. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol 1998;16:3121-3128 (Pubitemid 28417435)
5. Imoto H, Osaki T, Taga S, et al. Vasculae endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamouse cell carcinoma. J Thorac Cardiovasc Surg 1998;115:1007-1014 (Pubitemid 28224393)
6. Saito H, Tsujitani S, Kondo A, et al. Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma. Surgery 1999;125:195-201. (Pubitemid 29076116)
7. Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 2000;18:2046-2052 (Pubitemid 30324357)
8. Poon RT, Fan ST, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001;19:1207-1225 (Pubitemid 32176299)
9. Miyake H, Hara I, Yamanaka K, et al. Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer. Urology 1999;53:302-307 (Pubitemid 29063316)
10. Werther K, Christensen IJ, Nielsen HJ. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer 2002;86:417-423 (Pubitemid 34185127)
11. Karayiannakis AJ, Syrigos KN, Polychronidis A, et al. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 2002;236:37-42. (Pubitemid 34686448)
12. Teknos TN, Cox C, Yoo S, et al. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck 2002;24:1004-1011 (Pubitemid 35217110)
13. Cooper BC, Ritchie JM, Broghammer CL, et al. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clin Cancer Res 2002;8:3193-3197 (Pubitemid 35155030)
14. Poon RT, Ho JW, Tong CS, et al. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br J Surg 2004;91:354-360 (Pubitemid 39331462)
15. Kaya M, Wada T, Akatsuka T, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 2000;6:572-577 (Pubitemid 30111481)
16. Lee YH, Tokunaga T, Oshika Y, et al. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 1999;35:1089-1093 (Pubitemid 29339192)
17. Holzer G, Obermair A, Koschat M, et al. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors. Med Pediatr Oncol 2001;36:601-604 (Pubitemid 32402155)
18. Rutkowski P, Kaminska J, Kowalska M, Steffen J. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients correlations with local tumor extent and prognosis. J Surg Oncol 2003;84:151-159 (Pubitemid 37363158)
19. Kaya M, Wada T, Kawaguchi S, et al. Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma. Br J Cancer 2002;86:864-869 (Pubitemid 34271020)
20. El-Houseni ME, Abdel-Azim SA, El-Desouky GI, et al. Clinical significance of vascular endothelial growth factor (VEGF) in sera of patients with pediatric malignancies. J Egypt Natl Canc Inst 2004;16:57-61.